Dolby Laboratories, Inc. cash flow statement DLB

In fiscal 2025, which ended Sep 26, 2025, Dolby Laboratories, Inc. generated $472.2 million of cash from operations, up 44.3% from the year before. It spent $36.3 million on capital expenditures. That left free cash flow of $435.9 million. The company returned $126.6 million in dividends and $125.0 million in share buybacks to shareholders.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 26, 2026
FY 2025
Sep 26, 2025
FY 2024
Sep 27, 2024
FY 2023
Sep 29, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 24, 2021
FY 2020
Sep 25, 2020
FY 2019
Sep 27, 2019
FY 2018
Sep 28, 2018
FY 2017
Sep 29, 2017
FY 2016
Sep 30, 2016
Operating
Depreciation and amortization
93
+6.5%
88
+16.2%
76
-8.5%
83
-6.7%
88
-7.7%
96
+5.5%
91
+6.8%
85
+4.7%
81
-3.6%
84
-1.0%
85
+23.2%
Stock-based compensation
130
+2.2%
129
+7.3%
120
+1.1%
118
+3.1%
115
+15.3%
100
+15.1%
87
+13.1%
77
+7.5%
71
+9.0%
65
-2.5%
67
-0.1%
Operating cash flow
438
-6.0%
472
+44.3%
327
-10.9%
367
+15.2%
319
-28.9%
448
+30.2%
344
+4.9%
328
-7.0%
352
-6.8%
378
+4.9%
360
+16.4%
Investing
Capital expenditures
45
+63.5%
36
+21.1%
30
-1.1%
30
-36.7%
48
-12.0%
54
-17.9%
66
-31.1%
96
+32.2%
73
-26.9%
100
-1.1%
101
-36.0%
Investing cash flow
-77
+69.4%
-11
+96.3%
-286
-628.2%
54
+118.3%
-296
-559.0%
-45
-133.4%
134
+339.0%
-56
-172.0%
78
+149.4%
-158
+44.1%
-282
-38.8%
Financing
Dividends paid
134
+8.6%
127
+10.5%
115
+10.8%
103
+3.3%
100
+12.2%
89
+0.7%
89
+14.3%
77
+17.1%
66
+15.9%
57
+17.9%
48
+18.0%
Stock buybacks
235
+113.7%
125
-21.9%
160
+7.2%
149
-71.9%
530
+115.8%
246
+41.5%
174
-49.0%
341
+126.3%
150
+50.5%
100
-0.8%
101
-6.1%
Financing cash flow
-377
-54.9%
-247
+14.1%
-288
-21.5%
-237
+61.2%
-611
-141.8%
-253
-21.5%
-208
+46.1%
-385
-188.3%
-134
-25.1%
-107
-16.1%
-92
+33.6%
Change in cash
Effect of exchange rate
—
—
—
—
—
3
-30.9%
4
+167.7%
-6
-0.8%
-6
-444.9%
2
+220.1%
-1
+63.4%
Net change in cash
-18
+19.9%
216
+189.8%
-240
-226.7%
190
+131.4%
-605
-495.1%
153
-44.2%
274
—
—
—
—
Free cash flow
393
-10.4%
436
+46.6%
297
-11.7%
337
+24.4%
271
-31.2%
393
+41.7%
278
+19.9%
231
-17.2%
279
+0.4%
278
+7.3%
259
+70.8%
Per share
Free cash flow per share
4.08
-9.2%
4.47
+46.4%
3.05
-11.4%
3.45
+29.8%
2.65
-29.4%
3.76
+39.5%
2.70
+21.8%
2.21
-15.3%
2.61
-3.0%
2.69
+6.4%
2.53
+73.2%
Dividend per share
1.41
+6.8%
1.32
+7.3%
1.23
+10.8%
1.11
+8.8%
1.02
+12.1%
0.91
+3.4%
0.88
+11.4%
0.79
+17.9%
0.67
+15.5%
0.58
+16.0%
0.50
+19.0%
Shareholder returns
Returned to shareholders
369
252
275
253
631
335
262
418
217
157
149
Share of free cash flow
94.04%
57.72%
92.37%
75.04%
232.98%
85.19%
94.53%
180.68%
77.54%
56.46%
57.56%
Ratios
Free cash flow margin
28.99%
32.31%
23.34%
25.91%
21.59%
30.70%
23.89%
18.64%
26.49%
25.75%
25.28%
Capital expenditures to revenue
3.32%
2.69%
2.36%
2.33%
3.82%
4.25%
5.71%
7.75%
6.90%
9.22%
9.82%
Stock-based compensation to revenue
9.59%
9.53%
9.41%
9.12%
9.17%
7.78%
7.46%
6.17%
6.76%
6.05%
6.53%
Cash conversion
1.93x
1.85x
1.25x
1.83x
1.73x
1.44x
1.49x
1.28x
8.44x
1.83x
1.94x
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Patent Owners & Lessors (SIC 6794)
Listed as
DLB (NYSE)
Fiscal year ends
September 27
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1308547

Other Patent Owners & Lessors companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.